Transaction in Own Shares

Fidelity Emerging Markets Limited repurchased for cancellation 20,899 shares on 05 February 2026 at an average price of 1,203.65 GBp (low 1,198.00 GBp, high 1,206.00 GBp). Following the transaction the company’s issued share capital is 52,290,453, treasury holdings are 9,025,940 and total voting rights are 43,264,514; the repurchase is small in scale relative to issued capital and is unlikely to materially affect market valuation or voting control.

Analysis

Market structure: The 20,899‑share buyback (~0.04% of issued) is economically immaterial day‑to‑day but signal‑rich for closed‑end EM funds: winners are long holders of Fidelity Emerging Markets Ltd and other UK‑listed EM CEFs where buybacks compress discounts; losers are arbitrageurs short discounts expecting passive supply. Competitive dynamics shift marginally toward active closed‑end managers who demonstrate capital‑return discipline, potentially attracting flows from passive EM ETFs if buybacks become sustained (see treasury stock = 9.03m ≈17.3% of issued as optionality). Cross‑asset impact is negligible on sovereign bonds/FX/commodities absent a larger program, though a sustained buyback cadence could modestly boost local‑EM equity beta vs. DM by a few basis points.

Risk assessment: Tail risks include a rapid EM NAV shock (−15%+ over 1–3 months) that overwhelms any discount tightening, regulatory changes to UK CEF rules, or insider signalling that buybacks cease — low probability but high impact. Immediate (days) effect: none; short term (weeks–months): potential discount re‑rating if buybacks continue or a tender offer is announced; long term (quarters) the key is cumulative share retirements — if management repurchases >0.25% monthly (~131k shares) expect measurable NAV per share lift. Hidden dependency: buybacks funded by liquidating positions could indicate portfolio trimming and worse future returns; monitor NAV composition and turnover.

Trade implications: Direct: small tactical longs in UK‑listed EM closed‑end funds (e.g., Fidelity Emerging Markets Ltd (LSE: FEM)) if trading >200–400bp discount to peers, horizon 3–6 months. Pair trade: long FEM (1–2% portfolio) vs short EEM (1%) to isolate discount‑narrowing while hedging EM beta, target 200–400bp discount compression. Options: write 1–3 month 5–8% OTM covered calls on FEM to harvest yield if position is taken or buy 3‑6 month calls on EEM to express leveraged EM exposure with defined downside.

Contrarian angles: The market underestimates the optionality in the 9.03m treasury shares — management can reissue or cancel, producing asymmetric outcomes. Reaction is underdone: a small repurchase today is often a probe; if buybacks scale to even 0.5–1% monthly the NAV per share lift could be 6–12% annualized, which markets misprice today. Historical parallel: CEFs that moved from ad‑hoc to sustained buybacks (2012–2015 UK trusts) saw discounts compress 300–500bp within 6–12 months. Unintended consequence: aggressive repurchases funded by selling liquid EM positions would lower future alpha and can be a sell signal; therefore watch NAV changes post‑repurchase.

Key Decisions for Investors

• Establish a tactical 1–2% long position in Fidelity Emerging Markets Ltd (LSE: FEM) if the discount to NAV is ≥10% and buybacks continue; target a 200–400bp tightening within 3–6 months, take profits at +12–15% or if NAV falls >8% from entry (stop‑loss).
• Implement a pair trade: long FEM (1–2%) vs short iShares MSCI Emerging Markets ETF (NYSE: EEM) (1%) to hedge EM beta; close if discount compression <100bp in 6 months or NAV shock >12%.
• If holding FEM, sell 1–3 month covered calls ~5–8% OTM to collect yield (~annualized 8–20% depending on premium); roll if premium >1.5x theta decay expectation or if buyback cadence increases materially.
• Increase exposure to UK‑listed EM closed‑end funds to 3–5% total only if management consistently repurchases ≥0.25% monthly (~131k shares) for two consecutive months or announces a tender offer; otherwise cap exposure at 1–2% due to buyback execution risk.